Kamal S. Saini - Concepedia

Author

Kamal S. Saini

Also Known As

Dr. Kamal Saini, K S Saini, K Saini, K. S. Saini, K. Saini, K. V. Saini, K.S. Saini, KS Saini, Kamal S Saini, Kamal S. Saini

170

Publications

Citations

H-Index

Concepts

All Affiliations

Université Libre de Bruxelles Institut Jules Bordet European Institute of Oncology Covance (United States)University of Milan

About

Kamal S. Saini is an author at Université Libre de Bruxelles specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.1K
2	Health Sciences	3	3	227
3	Engineering	1	1	82
4	Natural Sciences	1	1	23
5	Nursing	1	1	207

Kamal S. Saini

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer Kamal S. Saini, Sherene Loi, Evandro de Azambuja, Cancer Treatment Reviews Breast OncologyOncologyMedicineRaf/mek/erk PathwaysBreast Cancer	2013	370
DNA methylation profiling reveals a predominant immune component in breast cancers Sarah Dedeurwaerder, Christine Desmedt, Emilie Calonne, EMBO Molecular Medicine	2011	229
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries Kamal S. Saini, Catherine Taylor, Antonio J. Ramírez, Annals of Oncology NursingBreast OncologyHealth PolicyBreast Cancer ManagementLarge International Survey	2011	207
Oxycodone and morphine have distinctly different pharmacological profiles: Radioligand binding and behavioural studies in two rat models of neuropathic pain Carsten K. Nielsen, F. B. Ross, Shahrdad Lotfipour, Pain Pain MedicineNeuropathic PainRat ModelsMolecular PainS.c. Oxycodone	2007	183
Effect of the COVID-19 pandemic on cancer treatment and research Kamal S. Saini, Begoña de las Heras, Javier de Castro, The Lancet Haematology	2020	159
Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence José Roberto Freitas Rossari, Otto Metzger, Marianne Paesmans, Journal of Oncology	2012	102
Effect of length of carbon nanotubes on electromagnetic interference shielding and mechanical properties of their reinforced epoxy composites Bhanu Pratap Singh, Kamal S. Saini, Veena Choudhary, Journal of Nanoparticle Research Materials ScienceReinforcement MaterialEngineeringMechanical EngineeringComposite Technology	2013	82
Genomic grade adds prognostic value in invasive lobular carcinoma Otto Metzger, Stefan Michiels, François Bertucci, Annals of Oncology Tumor BiologyTumor HeterogeneityMedicinePathologyCancer Genomics	2012	80
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection Sherene Loi, Criscitiello, Fumagalli, OncoTargets and Therapy Molecular BiomarkersBreast OncologyBreast Cancer EventsBreast Cancer PatientsPatient Selection	2010	62
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy Kamal S. Saini, Carlo Lanza, Marco Romano, British Journal of Cancer	2020	46

Page 1